<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00748735</url>
  </required_header>
  <id_info>
    <org_study_id>MB-2008-CRT</org_study_id>
    <nct_id>NCT00748735</nct_id>
  </id_info>
  <brief_title>Left Ventricular Lead Position in Cardiac Resynchronization Therapy</brief_title>
  <official_title>Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy by Myocardial Deformation Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left ventricular (LV) lead position has crucial impact on cardiac resynchronization therapy
      (CRT) success. This study will compare fluoroscopy and myocardial deformation imaging for
      optimal definition of LV lead position.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a 16 segment model circumferential strain will be used to determine the segment with
      latest peak systolic circumferential strain prior to CRT, considered as the optimal LV lead
      target. LV lead will be defined by (1) fluoroscopy, (2) the maximal temporal difference of
      peak circumferential strain before-to-on CRT and (3) the earliest peak systolic
      circumferential strain during LV pacing. For all 3 modalities optimal LV lead position is
      defined as concordance or immediate neighbouring of the segment with defined LV lead position
      to the determined optimal target segment. At follow-up echocardiography will be performed to
      determine improvement in LV function and remodeling.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in LV function and LV remodelling</measure>
    <time_frame>6 to 12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">55</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>A1</arm_group_label>
    <description>heart failure patients undergoing CRT implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implantation of a cardiac resynchronization therapy device</intervention_name>
    <arm_group_label>A1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echocardiography (myocardial deformation imaging)</intervention_name>
    <arm_group_label>A1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with end-stage heart failure and sinus rhythm, scheduled for new
        implantation of a biventricular pacemaker were included in the study. Criteria for CRT
        implantation were New York Heart Association (NYHA) functional class III (N=35) or IV
        (N=21) despite optimal pharmacologic therapy and evidence of LV systolic dysfunction with
        ejection fraction &lt;35% and a QRS &gt;120ms.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  See above

          -  Males and females

          -  Ages 18 to 80 years

        Exclusion Criteria:

          -  Patients who already have had a pacemaker device

          -  Patients with poor echocardiographic window

          -  Patients who are not able to understand the study and to give informed written consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Becker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rainer Hoffmann, MD</last_name>
    <role>Study Chair</role>
    <affiliation>RWTH Aachen University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiology, RWTH Aachen University Hospital</name>
      <address>
        <city>Aachen</city>
        <zip>52057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Becker M, Franke A, Breithardt OA, Ocklenburg C, Kaminski T, Kramann R, Knackstedt C, Stellbrink C, Hanrath P, Schauerte P, Hoffmann R. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study. Heart. 2007 Oct;93(10):1197-203. Epub 2007 Feb 19.</citation>
    <PMID>17309913</PMID>
  </reference>
  <reference>
    <citation>Becker M, Kramann R, Franke A, Breithardt OA, Heussen N, Knackstedt C, Stellbrink C, Schauerte P, Kelm M, Hoffmann R. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography. Eur Heart J. 2007 May;28(10):1211-20. Epub 2007 Apr 10.</citation>
    <PMID>17426079</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2008</study_first_submitted>
  <study_first_submitted_qc>September 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2008</study_first_posted>
  <last_update_submitted>September 8, 2008</last_update_submitted>
  <last_update_submitted_qc>September 8, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2008</last_update_posted>
  <keyword>cardiac resynchronization therapy</keyword>
  <keyword>echocardiography</keyword>
  <keyword>heart failure</keyword>
  <keyword>left ventricular function</keyword>
  <keyword>pacing</keyword>
  <keyword>myocardial deformation imaging</keyword>
  <keyword>Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

